These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 1929745)

  • 1. [Congenital hypothyroidism. Therapeutic strategy at the early stage of treatment].
    Touati G; Léger J; Czernichow P
    Arch Fr Pediatr; 1991; 48(7):461-5. PubMed ID: 1929745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G; Rapa A; Boccardo G; Silvestro L; Chiorboli E
    Minerva Endocrinol; 1999 Jun; 24(2):51-5. PubMed ID: 10941423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel therapeutic paradigm to treat congenital hypothyroidism.
    Mathai S; Cutfield WS; Gunn AJ; Webster D; Jefferies C; Robinson E; Hofman P
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):142-7. PubMed ID: 18598275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormonal therapy of congenital hypothyroidism in childhood].
    Rondanini GF; Focarile F; Bollati A; Bianchi C
    Pediatr Med Chir; 1983; 5(6):473-6. PubMed ID: 6681055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of the plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism.
    Bakker B; Kempers MJ; De Vijlder JJ; Van Tijn DA; Wiedijk BM; Van Bruggen M; Vulsma T
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):529-37. PubMed ID: 12354136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
    Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial treatment dose of L-thyroxine in congenital hypothyroidism.
    Selva KA; Mandel SH; Rien L; Sesser D; Miyahira R; Skeels M; Nelson JC; Lafranchi SH
    J Pediatr; 2002 Dec; 141(6):786-92. PubMed ID: 12461494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy.
    Saravanan P; Siddique H; Simmons DJ; Greenwood R; Dayan CM
    Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):261-7. PubMed ID: 17479444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of L-thyroxine replacement therapy in children with congenital hypothyroidism.
    Chiovato L; Giusti L; Tonacchera M; Ciampi M; Mammoli C; Lippi F; Lapi P; Bargagna S; Dini P; Ferretti G
    J Endocrinol Invest; 1991 Dec; 14(11):957-64. PubMed ID: 1806614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thyroxine dosage of 8 micrograms/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism.
    Touati G; Léger J; Toublanc JE; Farriaux JP; Stuckens C; Ponte C; David M; Rochiccioli P; Porquet D; Czernichow P
    Eur J Pediatr; 1997 Feb; 156(2):94-8. PubMed ID: 9039509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-1 and IGFBP-3 in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G; Rapa A; Boccardo G; Silvestro L; Chiorboli E
    Panminerva Med; 1998 Jun; 40(2):103-6. PubMed ID: 9689829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of FT4 serum in newborns at risk for congenital hypothyroidism (CH).
    Cordova RA; Vignola G
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():152-3. PubMed ID: 15906723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alpha fetoprotein in congenital hypothyroidism before and during treatment].
    Toublanc JE; Ingrand J; Megarbane M; Fulla Y; Rives S
    Arch Pediatr; 1994 Oct; 1(10):872-8. PubMed ID: 7531094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of the ultrasensitive assay of plasma TSH for the surveillance of replacement treatment in children with congenital hypothyroidism].
    Raux Demay MC; Silvain A; Girard F
    Arch Fr Pediatr; 1988 Oct; 45(8):549-52. PubMed ID: 3214248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high versus low initial doses of L-thyroxine for congenital hypothyroidism on thyroid function and somatic growth.
    Jones JH; Gellén B; Paterson WF; Beaton S; Donaldson MD
    Arch Dis Child; 2008 Nov; 93(11):940-4. PubMed ID: 18456702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the parameters used in monitoring hypothyroid patients treated with L-thyroxine].
    Custro N; Scafidi V; Indovina I
    Minerva Med; 1986 Dec; 77(47-48):2227-33. PubMed ID: 3101002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of perinatal asphyxia on thyroid-stimulating hormone and thyroid hormone levels.
    Pereira DN; Procianoy RS
    Acta Paediatr; 2003; 92(3):339-45. PubMed ID: 12725550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of L-thyroxine replacement.
    Burnett JR; Cooke R; Crooke MJ; Feek CM
    N Z Med J; 1992 Mar; 105(930):105-6. PubMed ID: 1553113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head circumference and linear growth during the first 3 years in treated congenital hypothyroidism in relation to aetiology and initial biochemical severity.
    Ng SM; Wong SC; Didi M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):155-9. PubMed ID: 15212659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.